China is picking up the fight against rare diseases

Bacteria

(Michael Schiffer, Unsplash)

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: Pius Hornstein, General Manager and Country Chair, Sanofi China


“Health is a prerequisite for people’s all-round development and a precondition for economic and social development.” So noted President Xi Jinping in an address to the senior leaders of the Chinese Communist Party in August 2016.

A few months later, with the adoption of the “Healthy China 2030” roadmap by the Chinese government, the country confirmed its ambition to include health in all policies and to link health to economic progress.

“Healthy China 2030” is the most ambitious illustration of China’s efforts to reform its healthcare system. Over the last 20 years, the country made great strides by investing massively in its health facilities and by raising the skills level of its health workers.

But more importantly, China has brought its population close to universal health coverage, thanks to the expansion of government-funded basic medical insurance. This achievement led Dr. Tedros Adhanom, Director-General of the World Health Organization, to acknowledge that the country was “leading by example on universal health coverage.”

Size of the Chinese healthcare market

Dealing with the unique challenges of rare diseases

On the road towards universal health coverage, governments across the world tend to first focus on addressing the most common conditions and primary care, temporarily putting aside those who suffer from rare conditions.

Globally, it is estimated that there are between 5,000 and 8,000 rare diseases. Most of them have a genetic origin and manifest in childhood. They are also often degenerative and life-threatening.

These diseases pose unique challenges to healthcare systems because they require specific medical expertise and significant diagnostic and screening capacities.

More importantly, they also pose unique challenges to patients and their families, who often find themselves isolated and sometimes spend years in search of proper diagnosis.

China’s efforts to prioritize the diagnosis and treatment of rare diseases remained nascent in the first waves of the healthcare system reform and efforts to get to universal coverage. But the need is clear and significant. In a country of around 1.4 billion people, “rare” translates to millions of people who suffer from these diseases. It is estimated that up to 20 million Chinese people suffer from a rare condition.

The government is now keen to catch up and has made rare diseases a public health priority as part of its 2030 roadmap.

In May 2018, the Chinese authorities published a list of rare diseases, covering 121 indications, including multiple sclerosis, Gaucher and Fabry diseases, and haemophilia.

The National Medical Products Administration – China’s pharmaceutical regulator – last year opened the possibility of fast track regulatory review for the registration of certain rare disease medicines.

Looking forward: ensuring that no one is left behind

The importance of rare diseases on the Chinese health and political agenda is growing. The government’s ambition to address rare diseases goes along with China’s new economic development journey, which includes a stronger focus on inclusive and high-quality growth.

In February 2019, Premier Li Keqiang called for further engagement in the fight against rare diseases. As with some cancer medicines the year before, the decision was made to cut the value-added tax rate (from 16% to 3%) for some rare disease medicines, in order to accelerate the launch of new treatments and incentivize their development.

As positive as these developments are, there are still many challenges to overcome to ensure that all Chinese people suffering from a rare disease have access to diagnosis and treatment.

In China and across the world, scarce diagnostic capabilities are one of the main challenges for rare disease patients. Many patients wait years to receive a correct diagnosis.

Ensuring greater knowledge and awareness of rare diseases among healthcare professionals is a basic but fundamental step. Likewise, putting in place early diagnosis and screening schemes can support better identification of patients.

Technology and big data can also be leveraged. Chinese authorities are working to establish databases to better understand the current epidemiology as well as research for future treatments.

Given the scarcity of rare disease patient data, there is the potential to improve the diagnosis and treatment of rare diseases in the near future with an increased use of Real World Evidence. This is derived from observational data obtained outside the context of randomized controlled trials, and the Chinese authorities have recently published draft guidelines for its use.

At the moment, though, several barriers hinder access to already existing treatments. Too many patients face significant out-of-pocket costs that put access to the treatment they need out of their reach. Those who are living in the largest cities of the country can be supported by local funding plans but, at a national level, only partial reimbursement is provided and rare disease treatments have yet to be included in the national drug reimbursement list.

As they work to incentivize the development and registration of medicines addressing rare conditions, establishing a special funding scheme for rare diseases at a national level would enable Chinese authorities to further improve their access and reimbursement policies.

Despite these challenges, it is clear that the recent and positive decisions taken by the government and the increased mobilization of actors in the system – patient groups, physicians, and the pharmaceutical industry – have sparked hope for millions of Chinese patients.

As China’s role and leadership in the global arena increases, other developing countries will be watching to see what can be learned from its approach to helping people suffering from rare diseases, and ensuring that nobody is left behind.

Advertising

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Governments adopt UN global migration pact to help ‘prevent suffering and chaos’

This massive project in Spain is the latest milestone in Europe’s solar power boom

Continuing incarceration of women’s rights activists in Saudi Arabia, ‘reprehensible’: UN experts

Ongoing insecurity in Darfur, despite ‘remarkable developments’ in Sudan: UN peacekeeping chief

Youth employment crisis easing but far from over

The jobs forecast is unsettled. It’s time for a reskilling revolution

How I met the Panda Woman

EU Commission: Germany can make Eurozone grow again just by helping itself

Imported and EU fisheries products should be treated equally

Worth going ‘extra mile’ for a new Syrian constitution, UN envoy urges

UN chief calls for ‘far greater support’ for Cyclone Idai response

EU Commission: The banks are not obliged to finance the real economy

The European Sting @ European Business Summit 2014 – the preview

Malta: investigation risks being compromised while Prime Minister is in office

Von der Leyen on Europe Day: What does Europe mean to me and why is solidarity more valid than ever

Black Panther’s ‘General Okoye’ joins the fight against gender-based violence

Parliament elects the von der Leyen Commission

‘Provocative actions and inflammatory rhetoric’ destabilizing Middle East, warns top UN official

How close is the new financial Armageddon? IMF gives some hints

Inspired by orange peel, this ‘plastic’ packaging is totally compostable

UN launches new project to address link between terrorism, arms and crime

We need to protect 30% of the planet by 2030. This is how we can do it

Cohesion Policy: EU invests €880 million to improve Poland’s railway system

‘Safe Eurobonds’: a new trick to betray the south euro area countries

The 2019 European elections: A pro-European – and young – electorate with clear expectations

Back to school: Schoolchildren to receive milk, fruits and vegetables at school thanks to EU programme

G20: Less growth, more austerity for developing countries

Why we need to rethink geo-economics to beat climate change

Why vaccines are not just for children

People are scared of artificial intelligence – here’s why we should embrace it instead

Developing countries should not be liable for emissions ‘accumulated throughout history’, key UN development forum hears

The Red Cross’s health chief explains how business must respond to coronavirus

Climate change recognized as ‘threat multiplier’, UN Security Council debates its impact on peace

Africa Forum aims to boost business, reduce costs, help countries trade out of poverty

SMEs are the most valuable partners. Here’s why

It’s not just the protests. Here’s how young people are helping the planet

‘Bring to life’ precious moments caught on film or tape, UN agency urges on World Day

The EU Spring Summit set to challenge austerity

NEC @ European Business Summit 2014: The Digitally Enabled Grid

Mirrored classroom display highlights scale of massive education crisis

Europe is designing satellites that ‘surf’ their way past space debris

European Business Summit 2014: The role of youth entrepreneurship education in EU’s Strategy for Competitiveness

In tech-driven 21st century, achieving global development goals requires closing digital gender divide

The mental domain in times of a pandemic

How regenerative agroforestry could solve the climate crisis

UN launches plan to promote peace, inclusive growth in Africa’s Sahel

COP21 Breaking News_03 December: Argentina Accepts KP Amendment

Central America: drought, resulting crop losses threaten food security of two million people, UN warns

Hospitals in Yemen attacked, disrupting healthcare for thousands of vulnerable civilians

EU funds must reach media and creative sector, say MEPs

Multiprofessional action against the indiscriminate use of antibiotics

The business case for investing in sustainable plastics

Eurozone: Even good statistics mean deeper recession

The EU Commission predicts a decimated growth in the next years

Friday’s Daily Brief: UN chief in China, counter-terrorism, updates from Bangladesh, Mali and Mozambique

This start-up made doing good a business priority – and flourished

Drug laws must be amended to ‘combat racial discrimination’, UN experts say

An introduction to ‘Eco-Medical Literacy’ and its importance in shaping expert medical professionals

Here’s how to make ‘value-based healthcare’ a reality

Alexis Tsipras against internal and external “enemies” in pursue of a two-phase deal now

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s